Pan Deng, Xu Lin, Zhang Li-Xiao, Shi Da-Zhuo, Guo Ming
Department of Cardiovascular, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China.
Graduate School, Beijing University of Chinese Medicine, Beijing 100020, China.
World J Diabetes. 2024 Apr 15;15(4):712-723. doi: 10.4239/wjd.v15.i4.712.
Dyslipidemia is frequently present in patients with diabetes. The associations of remnant cholesterol and mortality remains unclear in patients with diabetes.
To explore the associations of remnant cholesterol with all-cause and cardiovascular mortality in patients with diabetes.
This prospective cohort study included 4740 patients with diabetes who participated in the National Health and Nutrition Examination Survey from 1999 through 2018. Remnant cholesterol was used as the exposure variable, and all-cause and cardiovascular mortality were considered outcome events. Outcome data were obtained from the National Death Index, and all participants were followed from the interview date until death or December 31, 2019. Multivariate proportional Cox regression models were used to explore the associations between exposure and outcomes, in which remnant cholesterol was modeled as both a categorical and a continuous variable. Restricted cubic splines (RCSs) were calculated to assess the nonlinearity of associations. Subgroup (stratified by sex, age, body mass index, and duration of diabetes) and a series of sensitivity analyses were performed to evaluate the robustness of the associations.
During a median follow-up duration of 83 months, 1370 all-cause deaths and 389 cardiovascular deaths were documented. Patients with remnant cholesterol levels in the third quartile had a reduced risk of all-cause mortality [hazard ratio (HR) 95% confidence interval (CI): 0.66 (0.52-0.85)]; however, when remnant cholesterol was modeled as a continuous variable, it was associated with increased risks of all-cause [HR (95%CI): 1.12 (1.02-1.21) per SD] and cardiovascular [HR (95%CI): 1.16 (1.01-1.32), per SD] mortality. The RCS demonstrated nonlinear associations of remnant cholesterol with all-cause and cardiovascular mortality. Subgroup and sensitivity analyses did not reveal significant differences from the above results.
In patients with diabetes, higher remnant cholesterol was associated with increased risks of all-cause and cardiovascular mortality, and diabetes patients with slightly higher remnant cholesterol (0.68-1.04 mmol/L) had a lower risk of all-cause mortality.
血脂异常在糖尿病患者中很常见。糖尿病患者中残留胆固醇与死亡率之间的关联尚不清楚。
探讨糖尿病患者残留胆固醇与全因死亡率和心血管死亡率之间的关联。
这项前瞻性队列研究纳入了4740例参加1999年至2018年美国国家健康与营养检查调查的糖尿病患者。将残留胆固醇用作暴露变量,将全因死亡率和心血管死亡率视为结局事件。结局数据来自国家死亡指数,所有参与者从访谈日期开始随访直至死亡或2019年12月31日。使用多变量比例Cox回归模型探讨暴露与结局之间的关联,其中残留胆固醇被建模为分类变量和连续变量。计算受限立方样条(RCS)以评估关联的非线性。进行亚组分析(按性别、年龄、体重指数和糖尿病病程分层)和一系列敏感性分析以评估关联的稳健性。
在中位随访期83个月期间,记录了1370例全因死亡和389例心血管死亡。残留胆固醇水平处于第三四分位数的患者全因死亡率风险降低[风险比(HR)95%置信区间(CI):0.66(0.52 - 0.85)];然而,当将残留胆固醇建模为连续变量时,它与全因死亡[HR(95%CI):每标准差1.12(1.02 - 1.21)]和心血管死亡[HR(95%CI):每标准差1.16(1.01 - 1.32)]风险增加相关。RCS显示残留胆固醇与全因死亡率和心血管死亡率之间存在非线性关联。亚组分析和敏感性分析未显示与上述结果有显著差异。
在糖尿病患者中,较高的残留胆固醇与全因死亡率和心血管死亡率风险增加相关,而残留胆固醇略高(在0.68 - 1.04 mmol/L之间)的糖尿病患者全因死亡率风险较低。